An advisory firm to the life science industry

What we do

Business development

Business development with pharmaceutical and biotech companies. 

Early stage company activities with venture investors and founders. 

Collaborations include companies like Pfizer, Novartis, Merck, Roche and Takeda.

Deals include out-licensing biologics and small molecules, in-licensing marketed drugs, technology licensing, and royalty deals.

 

Investor relations and fundraising

Company roadshows and investor relations including most recently Orbimed, Perceptive Investors, Merlin Nexus, Heights Capital, Biotech Value Fund, and NEA. 

Banker and analyst activities including Ladenberg, Oppenheimer, Leerink Partners, Roth, Wainwright, Maxim, and Aegis Capital. Total funds raised over $350 million.

Board membership and management team coaching

World class expert in strategy development, portfolio management and decision analysis at Fortune 500 companies. 

Organizational coaching and project consulting based on over 20 years of senior management experience, 

Who we are

Access to over 20 years of experience in senior biotech management

Steve Engle was Chairman and CEO of XOMA, a developer of antibody therapeutics for inflammatory, metabolic, oncology and other diseases. Prior to that, he was Chairman and CEO of La Jolla Pharmaceutical Company, which discovered the biology of B cell tolerance, developed the first B cell toleragen for lupus patients, and received an approvable letter from the FDA. Steve served as VP of Marketing for Cygnus, a drug delivery company, where he helped gain FDA approval of and launch Nicotrol for smoking cessation. 

Access to over 20 years of board leadership and contribution

Currently, Steve is Chairman of of the board of Prescient Therapeutics, a clinical stage oncology company, and Author-it Software Corporation, a developer of authoring software solutions for pharmaceutical and biotechnology companies. He is a Director on the board of AROA Biosurgery, a developer of regenerative medicine products,  

Access to a deep, worldwide network

Steven Engle has an extensive network of pharmceutical, biotech, investor and banking contacts. He is a former board member of BIO, Baybio, and BIOCOM and the Lupus Foundation of America.  He served  as the Chair of BIOCOM. He has helped create and manage long-term partnerships with all of the major Pharmaceutical companies.

Contact Us

Send Message

Averigon

Menlo Park, CA

USA